Institutional

Institut du Cerveau - ICM is seeking to recruit group leaders to reinforce its research in Neurophysiology, and welcomes applications for recruit highly talented individuals with the ambition to establish an internationally competitive research group...

NeoNeuro SAS and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group are pleased to announce that they have entered into a collaboration to validate the performance of the Aptamarker platform for Alzheimer's disease...

Bruce Appel, a professor at the University of Colorado, School of Medecine and Children’s Hospital Colorado, spoke at the Institut du Cerveau - ICM on the 9th January 2017. His work focuses on understanding PMN cells differentiation and could...

Claire Wyart (Inserm, Institut du Cerveau - ICM), head of the team " Optogenetic dissection of spinal circuits underlying locomotion ", is the recipient of two prestigious awards, the EMBO Young Investigator Program and the New York Stem Cell...

As a specialist in amyotrophic lateral sclerosis genetics, Edor Kabashi, leader of the team "Amyotrophic lateral sclerosis treatment : from genetics to zebrafish ", is the winner of an ERC Consolidator Grant.

Hans Hultborn, Professor at the University of Copenhagen, was invited at the Institut du Cerveau - ICM on April 11, 2016. He explains how to identify and study interneurons during locomotion.

Guido Gerig is Institute Professor at the Computer Science and Engineering Department of the NYU’s Tandon School of Engineering. Here, he gives us a glimpse at longitudinal neuroimagery, which allows doctors to follow patient progress over time.

Nikos K. Logothetis is a neuroscience professor at the Max Planck Institute and visited the Institut du Cerveau - ICM on December 14, 2015. In this interview, he explains how the NET-fMRI technique works, allowing scientists to record communications...

Ron R. Kopito, Professor of Biology at Stanford University, has been working for the last several years with his team on problems related to protein folding, which is notably affected in certain neurodegenerative diseases. In particular, protein...

The Behavioural Neuropsychiatry Unit (BNPU) is a clinical unit established in 2013 through the IHU-A-Institut du Cerveau - ICM in the framework of the “Investissements d’Avenir” in close cooperation with the APHP / Pitié Salpêtrière.

In the framework of the new national Plan for the study of neurogenerative diseases (2014-2019), seven regional centres of excellence in the field of neurodegenerative diseases were selected from among the 12 projects submitted.

The Institut du Cerveau - ICM and the IHU-A-Institut du Cerveau - ICM announced in June, 2015, the launching of the "Big Brain Theory" program. This call for projects will attribute grants for new projects initiated by the researchers, clinicians...